Sales and Marketing

Showing 15 posts of 11520 posts found.

imp_pologne2

Pierre Fabre’s triplet therapy makes strong showing in BRAF V600E-mutant metastatic colorectal cancer

July 8, 2019 Research and Development, Sales and Marketing Cancer, Pierre Fabre, colorectal cancer, pharma

Pierre Fabre chose the European Society for Medical Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer in Barcelona, Spain, to …
28246711066_52e38bc591_z

Government to set up express freight service for medicines in case of no-deal Brexit

July 8, 2019 Sales and Marketing Transport, brexit, government, no-deal, pharma, planning

The Department of Health and Social Care (DHSC) plans to spend £3 million on emergency transport solutions for medicines in …
shutterstock

Pfizer and Sangamo’s haemophilia A gene therapy shows promise at Phase 1/2

July 8, 2019 Research and Development, Sales and Marketing Pfizer, Sangamo, haemophilia, pharma

Pfizer and Sangamo Therapeutics have shared new Phase 1/2 data for their investigational SB-525 gene therapy in the treatment of …
8655563196_1c0f83c447_z

New urine test can diagnose and offer prognosis for prostate cancer

July 8, 2019 Sales and Marketing Cancer, oncology, pharma, prostate cancer, urine test

A new urine test can diagnose cases of aggressive prostate cancer more quickly than invasive biopsies. The test can also …
29496564944_a9faceb1c2_z

Trump says executive order will ensure US will pay lowest prices in the world for drugs

July 8, 2019 Sales and Marketing Trump, US, executive order, pharma, politics, pricing

President Donald Trump has said that the White House is working on a ‘favoured nation clause’ to ensure the United …
mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

July 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Mike Thompson, pharma

The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike Thompson is to retire from …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brenntag, Elizabeth Warren, HIV, Novartis, PrEP, cannabis, crispr, pharma

The top story of this week covered Novartis’ announcement that they did not send chemicals that could be used to …

NICE recommends Pfizer’s Vizimpro, rejects AstraZeneca’s Tagrisso, in non-small cell lung cancer

July 5, 2019 Medical Communications, Sales and Marketing Cancer, NHS, NICE, Pfizer, UK, Vizimpro, lung cancer, pharma

NICE has announced its decision to recommend Pfizer’s Vizimpro (Dacomitinib) in the treatment of non-small-cell lung cancer (NSCLC) – a …
dw-anzcxqaqavhl

FDA approves multiple myeloma therapy Xpovio despite safety concerns

July 4, 2019 Sales and Marketing FDA, Karyopharm, Xpovio, multiple myeloma, pharma

The FDA has made the controversial decision to approve the nuclear export inhibitor Xpovio (selinexor) from Karyopharm Therapeutics, in combination …
shutterstock_138095450_13

Prices hiked on 3,400 drugs in first half of 2019

July 4, 2019 Research and Development, Sales and Marketing abstruse, access, generics, pharma, prescription, pricing

There have been price hikes on more than 3,400 drugs in the United States in the first six months of …
alexion_sign

European approval for Alexion’s Ultomiris in rare blood disease

July 4, 2019 Sales and Marketing Alexion, Europe, Ultomiris, paroxysmal nocturnal haemoglobinuria

Alexion has received marketing authorisation from the European Commission for its long-acting C5 complement inhibitor Ultomiris (ravulizumab) in the treatment …
medicinal_cannabis_uk_review

UK Government call for more research into medicinal cannabis

July 4, 2019 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CBMP, Marijuana, UK, medicinal cannabis, pharma, politics

The British government has called for more research into cannabis-based medicinal products (CBMPs). In a paper published on 3 July, …
landing-hero-images1

ViiV’s Dovato approved in Europe as treatment option for HIV-1

July 3, 2019 Research and Development, Sales and Marketing Dovato, GSK, HIV, ViiV Healthcare, pharma

ViiV Healthcare, the specialist HIV firm majority owned by GSK, is celebrating the news that the European Commission has chosen …

US Government awarded new patent on preventative HIV drugs PrEP

July 3, 2019 Research and Development, Sales and Marketing Gilead, HHS, government, pharma

The Department of Health and Human Services (HHS) has been awarded a new patent on drugs that prevent HIV. The …

Roche’s Tecentriq scores CHMP recommendation in PD-L1+ metastatic triple-negative breast cancer

July 2, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Roche, breast cancer, pharma, tecentriq

Roche’s immunotherapy Tecentriq (atezolizumab) has been recommended by the EMA’s Committee for Medicinal Products for Human Use (CHMP) in combination …
The Gateway to Local Adoption Series

Latest content